Cargando…

Genetic Factors in Parkinson’s Disease

Detalles Bibliográficos
Autor principal:	Dorszewska, Jolanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924244/ https://www.ncbi.nlm.nih.gov/pubmed/24532981 http://dx.doi.org/10.2174/138920291408140206113810

Ejemplares similares

Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System
por: Dorszewska, Jolanta
Publicado: (2014)

Oxidative stress factors in Parkinson’s disease
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Genetic Variants in Diseases of the Extrapyramidal System
por: Oczkowska, Anna, et al.
Publicado: (2014)

Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2015)

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2013)

Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment
por: Rozycka, Agata, et al.
Publicado: (2013)

Molecular Factors Mediating Neural Cell Plasticity Changes in Dementia Brain Diseases
por: Kozubski, Wojciech, et al.
Publicado: (2021)

Molecular factors in migraine
por: Kowalska, Marta, et al.
Publicado: (2016)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Editorial: Insights into mechanisms underlying brain impairment in aging, volume II
por: Dorszewska, Jolanta, et al.
Publicado: (2023)

Selected Biomarkers of Oxidative Stress and Energy Metabolism Disorders in Neurological Diseases
por: Korczowska-Łącka, Izabela, et al.
Publicado: (2023)

Analysis of Genetic Variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a Possible Marker of Migraine
por: Kowalska, Marta, et al.
Publicado: (2020)

Migraine: Calcium Channels and Glia
por: Kowalska, Marta, et al.
Publicado: (2021)

Genetics of Parkinson's disease
por: Gasser, Thomas
Publicado: (2004)

Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer’s disease patients
por: Prendecki, Michal, et al.
Publicado: (2018)

Midnolin is a confirmed genetic risk factor for Parkinson’s disease
por: Obara, Yutaro, et al.
Publicado: (2019)

Genetics and Epigenetics of Parkinson's Disease
por: Coppedè, Fabio
Publicado: (2012)

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2019)

Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018
por: Zaprutko, Tomasz, et al.
Publicado: (2021)

Genetics and genomics of Parkinson’s disease
por: Lin, Michelle K, et al.
Publicado: (2014)

Genetic association of Parkinson's disease
Publicado: (2012)

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease
por: Huertas, Ismael, et al.
Publicado: (2017)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
por: Liu, Hui, et al.
Publicado: (2022)

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
por: Schneider, Susanne A., et al.
Publicado: (2020)

The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
por: Kowalska, Marta, et al.
Publicado: (2018)

Genetic Rat Models of Parkinson's Disease
por: Welchko, Ryan M., et al.
Publicado: (2012)

Human Genetic Variation and Parkinson’s Disease
por: Chung, Sun Ju
Publicado: (2010)

Cognitive Impairment in Genetic Parkinson's Disease
por: Planas-Ballvé, A., et al.
Publicado: (2021)

Prediction of Parkinson’s Disease Risk Based on Genetic Profile and Established Risk Factors
por: Chairta, Paraskevi P., et al.
Publicado: (2021)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2021)

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan
por: Fung, Hon-Chung, et al.
Publicado: (2006)

Genetic Analysis of Pathways to Parkinson Disease
por: Hardy, John
Publicado: (2010)

Entanglement of Genetics and Epigenetics in Parkinson’s Disease
por: van Heesbeen, H. J., et al.
Publicado: (2019)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
por: Chai, Chou, et al.
Publicado: (2013)

Parkinson's Disease: From Genetics to Clinical Practice
por: Clarimón, Jordi, et al.
Publicado: (2013)

Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews
por: Chen, Yancong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rakcs35lrmnf33s4ghl70a7n1g